Skip to main content
Journal of Biological Physics logoLink to Journal of Biological Physics
. 2006 Nov 9;32(3-4):209–229. doi: 10.1007/s10867-006-9013-0

Modelling the Electrical Activity of Pancreatic α-cells Based on Experimental Data from Intact Mouse Islets

Paul M Diderichsen 1, Sven O Göpel 2,
PMCID: PMC2651523  PMID: 19669464

Abstract

Detailed experimental data from patch clamp experiments on pancreatic α-cells in intact mouse islets are used to model the electrical activity associated with glucagon secretion. Our model incorporates L- and T-type Ca2+ currents, delayed rectifying and A-type K+ currents, a voltage-gated Na+ current, a KATP conductance, and an unspecific leak current. Tolbutamide closes KATP channels in the α-cell, leading to a reduction of the resting conductance from 1.1 nS to 0.4 nS. This causes the α-cell to depolarise from −76 mV to 33 mV. When the basal membrane potential passes the range between −60 and −35 mV, the α-cell generates action potentials. At higher voltages, the α-cell enters a stable depolarised state and the electrical activity ceases. The effects of tolbutamide are simulated by gradually reducing the KATP conductance (gK,ATP) from 500 pS to 0 pS. When gK,ATP is between 72 nS and 303 nS, the model generates action potentials in the same voltage range as the α-cell. When gK,ATP is lower than 72 nS, the model enters a stable depolarised state, and firing of action potentials is inhibited due to voltage-dependent inactivation of the Na+ and T-type Ca2+ currents. This is in accordance with experimental results. Changing the inactivation parameters to those observed in somatostatin-secreting δ-cells abolishes the depolarised inactive state, and leads to β-cell like electrical activity with action potentials generated even after complete closure of the KATP channels.

Key words: pancreatic α-cell, ion channel, inactivation, glucagon, membrane potential

References

  • 1.Göpel, S., Kanno, T., Barg, S., Weng, X.-G., Gromada, J., Rorsman, P.: Regulation of glucagon release in mouse α-cells by kATP channels and inactivation of TTX-sensitive Na+. J. Physiol. 528(3), 509–520 (2000) [DOI] [PMC free article] [PubMed]
  • 2.Göpel, S.O., Kanno, T., Barg, S., Rorsman, P.: Patch-clamp characterisation of somatostatin-secreting δ-cells in intact mouse pancreatic islets. J. Physiol. 528(3), 497–507 (2000) [DOI] [PMC free article] [PubMed]
  • 3.Gromada, J., Bokvist, K., Ding, W.G., Barg, S., Buschard, K., Renstrom, E., Rorsman, P.: Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J. Gen. Physiol. 110, 217–228 (1997) [DOI] [PMC free article] [PubMed]
  • 4.Rorsman, P., Hellman, B.: Voltage-activated currents in guinea pig pancreatic α2 cells. evidence for Ca2+-dependent action potentials. Br. J. Pharmacol. 91, 223–242 (1988) [DOI] [PMC free article] [PubMed]
  • 5.Berts, A., Ball, A., Gylfe, E., Hellman, B.: Suppression of Ca++ oscillations in glucagon-producing α2-cells by insulin/glucose and amino acids. Biochim. Biophys. Acta 1310, 212–216 (1996) [DOI] [PubMed]
  • 6.Nadal, A., Queseda, I., Soria, B.: Homologous and heterologous asynchronicity between identified α-,β- and δ-cells within intact islets of Langerhans in the mouse. J. Physiol. 517, 85–93 (1999) [DOI] [PMC free article] [PubMed]
  • 7.Bokvist, K., Olsen, H.L., Hoy, M., Gotfredsen, C.F., Holmes, W.F., Buschard, K., Rorsman, P., Gromada, J.: Characterization of sulfonylurea and ATP-regulated K+ channels in rat pancreatic A-cells. Pflügers Arch. 438(4), 428–436 (1999) [DOI] [PubMed]
  • 8.Rajan, A.S., Aguilar-Bryan, L., Nelson, D.A., Nichols, C.G., Wechsler, S.W., Lechago, J.: Sulfonylurea receptors and ATP-sensitive K+ channels in clonal pancreatic alpha cells. evidence for two high-affinity sulfonylurea receptors. J. Biol. Chem. 268(20), 15221–15228 (1993) [PubMed]
  • 9.Detimary, P., Dejonghe, S., Ling, Z., Pipeleers, D., Schuit, F., Henquin, J.: The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in β cells but not in α cells and are also observed in human islets. J. Biol. Chem. 273, 33905–33908 (1998) [DOI] [PubMed]
  • 10.Östenson, C.G., Agren, A., Brolin, S.E., Petersson, B.: Adenine nucleotide concentrations in A2-cell rich and normal pancreatic islets from guinea pig. Diabetes Metab. 6, 5–11 (1980) [PubMed]
  • 11.Bertram, R., Previte, J., Sherman, A., Kinard, T.A., Satin, L.S.: The phantom burster model for pancreatic beta-cells. Biophys. J. 79(6), 2880–2892 (2000) [DOI] [PMC free article] [PubMed]
  • 12.Chay, T.R., Keizer, J.: Minimal model for membrane oscillations in the pancreatic beta-cell. Biophys. J. 42(2), 181–190 (1983) [DOI] [PMC free article] [PubMed]
  • 13.Hille, B.: Ion Channels of Excitable Membranes. Sinauer Associates, Sunderland, Massachusetts (2001)
  • 14.Macianskiene, R., Viappiani, S.: Slowing of the inactivation of cardiac voltage-dependent sodium channels by the amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl) benzofuran (kb130015). J. Pharmacol. Exp. Ther. 304, 130–138 (2003) [DOI] [PubMed]
  • 15.Ronner, P., Matschinsky, F.M., Hang, T.L., Epstein, A.J., Buettger, C.: Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-tc glucagonoma and beta-tc insulinoma cells. Diabetes 42(12), 1760–1772 (1993) [DOI] [PubMed]
  • 16.Conley, E.C., Brammar, W.J.: The Ion Channel Facts Book: Voltage-gated Channels (volume 4). Academic, San Diego, California (1999)
  • 17.Rich, M.M., Pinter, M.J.: Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann. Neurol. 50, 26–33 (2001) [DOI] [PubMed]
  • 18.Massi-Benedetti, F., Flaorni, A., Luyckx, A., Lefebvre, P.: Inhibition of glucagon secretion in the human newborn by simultaneous administration of glucose and insulin. Horm. Metab. Res. 6, 392–396 (1974) [DOI] [PubMed]
  • 19.Samols, E., Tyler, J.M., Mialhe, P.: Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas. Lancet 7587, 174–176 (1969) [DOI] [PubMed]
  • 20.Vance, J.E., Buchanan, K.: Interrelationship between glucagon and insulin release from isolated islets of Langerhans. Diabetes 17, 311–312 (1968) [PubMed]
  • 21.Samols, E., Tyler, J.M., Marks, V.: Stimulation of glucagon secretion by oral glucose. Lancet 7425, 1257–1259 (1965) [DOI] [PubMed]
  • 22.Pek, S., Fajans, S.S., Floyd, J.C., Knopf, R.F., Conn, J.W.: Failure of sulfonylureas to suppress plasma glucagon in man. Diabetes 21, 216–223 (1972) [DOI] [PubMed]
  • 23.Loubatieres, A.L., Loubatieres-Mariani, M.M., Alric, R., Ribes, G.: Tolbutamide and glucagon secretion. Diabetologia 10(4), 271–276 (1974) [DOI] [PubMed]

Articles from Journal of Biological Physics are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES